Risk of capital impairment due to deteriorating performance and other factors
First written in FY2017. 16 of 20 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2022: 5 of 12 companies on the "Worse" side.
5 other companies' latest entry also says "Other".
- FY2025Full implementation of the finalized Basel III frameworkAnnual report
「We have applied the fully implemented finalised Basel III basis from the end of the current consolidated fiscal year. (Transitional measures have not been applied.)」
Regarding changes to capital ratio regulations, the company transitioned to the planned full implementation of the finalised Basel III. - FY2025-H1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2024-Q3RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2024-Q2RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2024-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document reiterates that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2023-Q2RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2023-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2022Change in the timing of the domestic implementation of Basel IIIAnnual report
「Following the domestic implementation of the finalised Basel III, scheduled for the fiscal year ending March 2025, calculations will be required based on the details of those changes.」
The description of the timing of the domestic implementation of the finalised Basel III changed from the previous schedule of the fiscal year ending March 2023 to the fiscal year ending March 2025. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2021Development of specific plans for the domestic implementation of Basel IIIAnnual report
「Following the domestic implementation of the finalized Basel III framework scheduled for the fiscal year ending March 2023, calculations will be required based on the relevant changes.」
Regarding the risk of erosion of shareholders’ equity, it specifically states that the method for calculating the capital ratio may change following the domestic implementation of the finalised Basel III, scheduled for the fiscal year ending March 2023. - FY2021-Q3RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document reiterates that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2021-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2020-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2019-Q3RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document reiterates that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2019-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2018-Q2RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2018-Q1RestatedAnnual report
「There have been no material changes to the matters described under “Business and Other Risks” in the annual securities report for the previous fiscal year.」
The document states that there have been no material changes concerning the risk of equity capital being impaired due to deteriorating business performance and other factors. - FY2017First statedAnnual report
「Risk of equity capital being impaired due to deteriorating business performance, the write-off of deferred tax assets and other factors」
The document identifies the possibility of equity capital being impaired as a result of deteriorating business performance, the write-off of deferred tax assets and other factors.